Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Management of Body Weight”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Not applicableStudy completedNCT01766882
What this trial is testing

Volume,Sodium and Blood Pressure Management in HD

Who this might be right for
End Stage Renal Failure
University of Michigan 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07169942
What this trial is testing

Aleniglipron Phase 2 Body Composition Study

Who this might be right for
Obesity, Overweight, or Chronic Weight Management
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 71
Testing effectiveness (Phase 2)Ended earlyNCT04801641
What this trial is testing

A Pilot Trial of Nabilone for the Treatment of Obesity

Who this might be right for
Obesity
Centre for Addiction and Mental Health 18
Early research (Phase 1)Study completedNCT05696847
What this trial is testing

Tirzepatide (LY3298176) in Pediatric Participants With Obesity

Who this might be right for
Obesity
Eli Lilly and Company 28
Post-approval studies (Phase 4)Study completedNCT05579249
What this trial is testing

A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America

Who this might be right for
Obesity
Novo Nordisk A/S 500
Not applicableLooking for participantsNCT07180368
What this trial is testing

Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients

Who this might be right for
Coronary Artery DiseaseDiabete MellitusChronic Kidney Disease+6 more
Xijing Hospital 2,000
Large-scale testing (Phase 3)Looking for participantsNCT07684144
What this trial is testing

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Who this might be right for
ObesityOverweightDiabetes Mellitus, Type 2
Amgen 950
Not applicableWithdrawnNCT00093678
What this trial is testing

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

Who this might be right for
CachexiaLymphomaMelanoma (Skin)+4 more
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT06703021
What this trial is testing

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Who this might be right for
ObesityOverweightChronic Weight Management
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 85
Large-scale testing (Phase 3)Looking for participantsNCT06672549
What this trial is testing

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Who this might be right for
ObesityOverweight
Eli Lilly and Company 125
Post-approval studies (Phase 4)UnknownNCT05594823
What this trial is testing

Flexible vs. Fixed Diuretic Regimen in the Management of Chronic Heart Failure: A Pilot Study

Who this might be right for
Heart FailureHeart Diseases
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 30
Testing effectiveness (Phase 2)Study completedNCT06671821
What this trial is testing

Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects

Who this might be right for
Chronic Weight Management
Shandong Suncadia Medicine Co., Ltd. 81
Large-scale testing (Phase 3)Not Yet RecruitingNCT07792954
What this trial is testing

Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity

Who this might be right for
ObesityOverweight
Pfizer 300
Early research (Phase 1)Study completedNCT06427590
What this trial is testing

Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Healthy and Obese Subjects

Who this might be right for
Chronic Weight Management
Ascletis Pharma (China) Co., Limited 28
Not applicableStudy completedNCT00489879
What this trial is testing

Management of Patients With Type 2 Diabetes and Hypertension Using Mobile Health Care System

Who this might be right for
DiabetesHypertensionObesity
Korea University 140
Testing effectiveness (Phase 2)Study completedNCT06679959
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ASC30 Injection in Participants With Obesity

Who this might be right for
Chronic Weight Management
Ascletis Pharma (China) Co., Limited 115
Post-approval studies (Phase 4)Study completedNCT01987427
What this trial is testing

A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults

Who this might be right for
Chronic Weight Management
Eisai Inc. 344
Not applicableStudy completedNCT03998878
What this trial is testing

Testing the Effect of Multiple Weight Management Modalities for Chronic Disease Risk Reduction in a Clinical Setting

Who this might be right for
Obesity
University of Arizona 9
Large-scale testing (Phase 3)Active Not RecruitingNCT06858878
What this trial is testing

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

Who this might be right for
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Amgen 1,105